Clinical outcome of renal tubular damage in chronic heart failure
Aims Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF). However, tubulo-interstitial injury might indicate renal damage, even in the presence of normal glomerular filtration. We studied the relations...
Gespeichert in:
Veröffentlicht in: | European heart journal 2011-11, Vol.32 (21), p.2705-2712 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2712 |
---|---|
container_issue | 21 |
container_start_page | 2705 |
container_title | European heart journal |
container_volume | 32 |
creator | Damman, Kevin Masson, Serge Hillege, Hans L. Maggioni, Aldo P. Voors, Adriaan A. Opasich, Cristina van Veldhuisen, Dirk J. Montagna, Laura Cosmi, Franco Tognoni, Gianni Tavazzi, Luigi Latini, Roberto |
description | Aims
Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF). However, tubulo-interstitial injury might indicate renal damage, even in the presence of normal glomerular filtration. We studied the relationship between tubular damage, glomerular filtration, urinary albumin excretion, and outcome in HF patients.
Methods and results
In 2130 patients participating in the GISSI-HF trial, we measured urinary albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), and three urinary markers of tubular damage: N-acetyl-beta-d-glucosaminidase (NAG), kidney injury molecule 1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL). We assessed the relationship between the individual tubular damage markers and the combined endpoint of all-cause mortality and HF hospitalizations. Mean age was 67 ± 11 years, and 21% were female. Urinary NAG 13.7 (7.8-22) U/gCr, KIM-1 1939 (671-3871) ng/gCr, and NGAL 36 (14-94) µg/gCr were markedly elevated above normal levels. All individual tubular markers were independently associated with the combined endpoint: NAG: adjusted hazard ratio (HR) 1.22; 95% confidence interval (CI), 1.10-1.36; P< 0.001, KIM-1 HR 1.13; 95% CI, 1.02-1.24; P= 0.018 and NGAL HR 1.10; 95% CI, 1.00-1.20; P= 0.042; all per log standard deviation increase). Even in patients with a normal eGFR, increased tubular markers were related to a poorer outcome. The combination of impaired eGFR, increased UACR, and high NAG was associated with a HR of 3.00; 95% CI, 2.29-3.95; P< 0.001, compared with those without these abnormalities.
Conclusion
Tubular damage is related to a poor clinical outcome in HF patients even when eGFR is normal.
ClinicalTrials.gov Identifier: NCT00336336 (for the main study). |
doi_str_mv | 10.1093/eurheartj/ehr190 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_902087554</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/eurheartj/ehr190</oup_id><sourcerecordid>902087554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-4a50802d29460b377d55264e98568c971694cfddc824d15277c8440dbf7aa2803</originalsourceid><addsrcrecordid>eNqFkDtPwzAURi0EoqWwMyEviAGF2q6fI6p4SZVYQGKLHNuhqZK42PHAv8eQUkamK12d77u6B4BzjG4wUou5S2HtdBg2c7cOWKEDMMWMkEJxyg7BFGHFCs7l2wScxLhBCEmO-TGYEMw5J1RNwe2ybfrG6Bb6NBjfOehrGFyfF0OqUqsDtLrT7w42PTTr4DMMf27CWjdtCu4UHNW6je5sN2fg9f7uZflYrJ4fnpa3q8JQQYaCaoYkIpYoylG1EMIyRjh1SjIujRKYK2pqa40k1OYnhDCSUmSrWmhNJFrMwNXYuw3-I7k4lF0TjWtb3TufYqkQQVIwRjOJRtIEH2NwdbkNTafDZ4lR-e2t3HsrR285crErT1Xn7D7wKyoDlztAx2yrDro3TfzjKF8IJkXmrkfOp-3_Z78AbZiHNQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>902087554</pqid></control><display><type>article</type><title>Clinical outcome of renal tubular damage in chronic heart failure</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Damman, Kevin ; Masson, Serge ; Hillege, Hans L. ; Maggioni, Aldo P. ; Voors, Adriaan A. ; Opasich, Cristina ; van Veldhuisen, Dirk J. ; Montagna, Laura ; Cosmi, Franco ; Tognoni, Gianni ; Tavazzi, Luigi ; Latini, Roberto</creator><creatorcontrib>Damman, Kevin ; Masson, Serge ; Hillege, Hans L. ; Maggioni, Aldo P. ; Voors, Adriaan A. ; Opasich, Cristina ; van Veldhuisen, Dirk J. ; Montagna, Laura ; Cosmi, Franco ; Tognoni, Gianni ; Tavazzi, Luigi ; Latini, Roberto</creatorcontrib><description>Aims
Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF). However, tubulo-interstitial injury might indicate renal damage, even in the presence of normal glomerular filtration. We studied the relationship between tubular damage, glomerular filtration, urinary albumin excretion, and outcome in HF patients.
Methods and results
In 2130 patients participating in the GISSI-HF trial, we measured urinary albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), and three urinary markers of tubular damage: N-acetyl-beta-d-glucosaminidase (NAG), kidney injury molecule 1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL). We assessed the relationship between the individual tubular damage markers and the combined endpoint of all-cause mortality and HF hospitalizations. Mean age was 67 ± 11 years, and 21% were female. Urinary NAG 13.7 (7.8-22) U/gCr, KIM-1 1939 (671-3871) ng/gCr, and NGAL 36 (14-94) µg/gCr were markedly elevated above normal levels. All individual tubular markers were independently associated with the combined endpoint: NAG: adjusted hazard ratio (HR) 1.22; 95% confidence interval (CI), 1.10-1.36; P< 0.001, KIM-1 HR 1.13; 95% CI, 1.02-1.24; P= 0.018 and NGAL HR 1.10; 95% CI, 1.00-1.20; P= 0.042; all per log standard deviation increase). Even in patients with a normal eGFR, increased tubular markers were related to a poorer outcome. The combination of impaired eGFR, increased UACR, and high NAG was associated with a HR of 3.00; 95% CI, 2.29-3.95; P< 0.001, compared with those without these abnormalities.
Conclusion
Tubular damage is related to a poor clinical outcome in HF patients even when eGFR is normal.
ClinicalTrials.gov Identifier: NCT00336336 (for the main study).</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehr190</identifier><identifier>PMID: 21666249</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Acetylglucosaminidase - urine ; Acute-Phase Proteins - urine ; Aged ; Albuminuria ; Biological and medical sciences ; Cardio-Renal Syndrome - physiopathology ; Cardio-Renal Syndrome - urine ; Cardiology. Vascular system ; Chronic Disease ; Female ; Glomerular Filtration Rate - physiology ; Heart ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Hepatitis A Virus Cellular Receptor 1 ; Humans ; Kidney Tubules - physiopathology ; Lipocalin-2 ; Lipocalins - urine ; Male ; Medical sciences ; Membrane Glycoproteins - urine ; Middle Aged ; Multicenter Studies as Topic ; Proto-Oncogene Proteins - urine ; Randomized Controlled Trials as Topic ; Receptors, Virus</subject><ispartof>European heart journal, 2011-11, Vol.32 (21), p.2705-2712</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2011. For permissions please email: journals.permissions@oup.com 2011</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-4a50802d29460b377d55264e98568c971694cfddc824d15277c8440dbf7aa2803</citedby><cites>FETCH-LOGICAL-c472t-4a50802d29460b377d55264e98568c971694cfddc824d15277c8440dbf7aa2803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24637587$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21666249$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Damman, Kevin</creatorcontrib><creatorcontrib>Masson, Serge</creatorcontrib><creatorcontrib>Hillege, Hans L.</creatorcontrib><creatorcontrib>Maggioni, Aldo P.</creatorcontrib><creatorcontrib>Voors, Adriaan A.</creatorcontrib><creatorcontrib>Opasich, Cristina</creatorcontrib><creatorcontrib>van Veldhuisen, Dirk J.</creatorcontrib><creatorcontrib>Montagna, Laura</creatorcontrib><creatorcontrib>Cosmi, Franco</creatorcontrib><creatorcontrib>Tognoni, Gianni</creatorcontrib><creatorcontrib>Tavazzi, Luigi</creatorcontrib><creatorcontrib>Latini, Roberto</creatorcontrib><title>Clinical outcome of renal tubular damage in chronic heart failure</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>Aims
Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF). However, tubulo-interstitial injury might indicate renal damage, even in the presence of normal glomerular filtration. We studied the relationship between tubular damage, glomerular filtration, urinary albumin excretion, and outcome in HF patients.
Methods and results
In 2130 patients participating in the GISSI-HF trial, we measured urinary albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), and three urinary markers of tubular damage: N-acetyl-beta-d-glucosaminidase (NAG), kidney injury molecule 1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL). We assessed the relationship between the individual tubular damage markers and the combined endpoint of all-cause mortality and HF hospitalizations. Mean age was 67 ± 11 years, and 21% were female. Urinary NAG 13.7 (7.8-22) U/gCr, KIM-1 1939 (671-3871) ng/gCr, and NGAL 36 (14-94) µg/gCr were markedly elevated above normal levels. All individual tubular markers were independently associated with the combined endpoint: NAG: adjusted hazard ratio (HR) 1.22; 95% confidence interval (CI), 1.10-1.36; P< 0.001, KIM-1 HR 1.13; 95% CI, 1.02-1.24; P= 0.018 and NGAL HR 1.10; 95% CI, 1.00-1.20; P= 0.042; all per log standard deviation increase). Even in patients with a normal eGFR, increased tubular markers were related to a poorer outcome. The combination of impaired eGFR, increased UACR, and high NAG was associated with a HR of 3.00; 95% CI, 2.29-3.95; P< 0.001, compared with those without these abnormalities.
Conclusion
Tubular damage is related to a poor clinical outcome in HF patients even when eGFR is normal.
ClinicalTrials.gov Identifier: NCT00336336 (for the main study).</description><subject>Acetylglucosaminidase - urine</subject><subject>Acute-Phase Proteins - urine</subject><subject>Aged</subject><subject>Albuminuria</subject><subject>Biological and medical sciences</subject><subject>Cardio-Renal Syndrome - physiopathology</subject><subject>Cardio-Renal Syndrome - urine</subject><subject>Cardiology. Vascular system</subject><subject>Chronic Disease</subject><subject>Female</subject><subject>Glomerular Filtration Rate - physiology</subject><subject>Heart</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Hepatitis A Virus Cellular Receptor 1</subject><subject>Humans</subject><subject>Kidney Tubules - physiopathology</subject><subject>Lipocalin-2</subject><subject>Lipocalins - urine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - urine</subject><subject>Middle Aged</subject><subject>Multicenter Studies as Topic</subject><subject>Proto-Oncogene Proteins - urine</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Receptors, Virus</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDtPwzAURi0EoqWwMyEviAGF2q6fI6p4SZVYQGKLHNuhqZK42PHAv8eQUkamK12d77u6B4BzjG4wUou5S2HtdBg2c7cOWKEDMMWMkEJxyg7BFGHFCs7l2wScxLhBCEmO-TGYEMw5J1RNwe2ybfrG6Bb6NBjfOehrGFyfF0OqUqsDtLrT7w42PTTr4DMMf27CWjdtCu4UHNW6je5sN2fg9f7uZflYrJ4fnpa3q8JQQYaCaoYkIpYoylG1EMIyRjh1SjIujRKYK2pqa40k1OYnhDCSUmSrWmhNJFrMwNXYuw3-I7k4lF0TjWtb3TufYqkQQVIwRjOJRtIEH2NwdbkNTafDZ4lR-e2t3HsrR285crErT1Xn7D7wKyoDlztAx2yrDro3TfzjKF8IJkXmrkfOp-3_Z78AbZiHNQ</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Damman, Kevin</creator><creator>Masson, Serge</creator><creator>Hillege, Hans L.</creator><creator>Maggioni, Aldo P.</creator><creator>Voors, Adriaan A.</creator><creator>Opasich, Cristina</creator><creator>van Veldhuisen, Dirk J.</creator><creator>Montagna, Laura</creator><creator>Cosmi, Franco</creator><creator>Tognoni, Gianni</creator><creator>Tavazzi, Luigi</creator><creator>Latini, Roberto</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20111101</creationdate><title>Clinical outcome of renal tubular damage in chronic heart failure</title><author>Damman, Kevin ; Masson, Serge ; Hillege, Hans L. ; Maggioni, Aldo P. ; Voors, Adriaan A. ; Opasich, Cristina ; van Veldhuisen, Dirk J. ; Montagna, Laura ; Cosmi, Franco ; Tognoni, Gianni ; Tavazzi, Luigi ; Latini, Roberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-4a50802d29460b377d55264e98568c971694cfddc824d15277c8440dbf7aa2803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acetylglucosaminidase - urine</topic><topic>Acute-Phase Proteins - urine</topic><topic>Aged</topic><topic>Albuminuria</topic><topic>Biological and medical sciences</topic><topic>Cardio-Renal Syndrome - physiopathology</topic><topic>Cardio-Renal Syndrome - urine</topic><topic>Cardiology. Vascular system</topic><topic>Chronic Disease</topic><topic>Female</topic><topic>Glomerular Filtration Rate - physiology</topic><topic>Heart</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Hepatitis A Virus Cellular Receptor 1</topic><topic>Humans</topic><topic>Kidney Tubules - physiopathology</topic><topic>Lipocalin-2</topic><topic>Lipocalins - urine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - urine</topic><topic>Middle Aged</topic><topic>Multicenter Studies as Topic</topic><topic>Proto-Oncogene Proteins - urine</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Receptors, Virus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Damman, Kevin</creatorcontrib><creatorcontrib>Masson, Serge</creatorcontrib><creatorcontrib>Hillege, Hans L.</creatorcontrib><creatorcontrib>Maggioni, Aldo P.</creatorcontrib><creatorcontrib>Voors, Adriaan A.</creatorcontrib><creatorcontrib>Opasich, Cristina</creatorcontrib><creatorcontrib>van Veldhuisen, Dirk J.</creatorcontrib><creatorcontrib>Montagna, Laura</creatorcontrib><creatorcontrib>Cosmi, Franco</creatorcontrib><creatorcontrib>Tognoni, Gianni</creatorcontrib><creatorcontrib>Tavazzi, Luigi</creatorcontrib><creatorcontrib>Latini, Roberto</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Damman, Kevin</au><au>Masson, Serge</au><au>Hillege, Hans L.</au><au>Maggioni, Aldo P.</au><au>Voors, Adriaan A.</au><au>Opasich, Cristina</au><au>van Veldhuisen, Dirk J.</au><au>Montagna, Laura</au><au>Cosmi, Franco</au><au>Tognoni, Gianni</au><au>Tavazzi, Luigi</au><au>Latini, Roberto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical outcome of renal tubular damage in chronic heart failure</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>32</volume><issue>21</issue><spage>2705</spage><epage>2712</epage><pages>2705-2712</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Aims
Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF). However, tubulo-interstitial injury might indicate renal damage, even in the presence of normal glomerular filtration. We studied the relationship between tubular damage, glomerular filtration, urinary albumin excretion, and outcome in HF patients.
Methods and results
In 2130 patients participating in the GISSI-HF trial, we measured urinary albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), and three urinary markers of tubular damage: N-acetyl-beta-d-glucosaminidase (NAG), kidney injury molecule 1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL). We assessed the relationship between the individual tubular damage markers and the combined endpoint of all-cause mortality and HF hospitalizations. Mean age was 67 ± 11 years, and 21% were female. Urinary NAG 13.7 (7.8-22) U/gCr, KIM-1 1939 (671-3871) ng/gCr, and NGAL 36 (14-94) µg/gCr were markedly elevated above normal levels. All individual tubular markers were independently associated with the combined endpoint: NAG: adjusted hazard ratio (HR) 1.22; 95% confidence interval (CI), 1.10-1.36; P< 0.001, KIM-1 HR 1.13; 95% CI, 1.02-1.24; P= 0.018 and NGAL HR 1.10; 95% CI, 1.00-1.20; P= 0.042; all per log standard deviation increase). Even in patients with a normal eGFR, increased tubular markers were related to a poorer outcome. The combination of impaired eGFR, increased UACR, and high NAG was associated with a HR of 3.00; 95% CI, 2.29-3.95; P< 0.001, compared with those without these abnormalities.
Conclusion
Tubular damage is related to a poor clinical outcome in HF patients even when eGFR is normal.
ClinicalTrials.gov Identifier: NCT00336336 (for the main study).</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>21666249</pmid><doi>10.1093/eurheartj/ehr190</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0195-668X |
ispartof | European heart journal, 2011-11, Vol.32 (21), p.2705-2712 |
issn | 0195-668X 1522-9645 |
language | eng |
recordid | cdi_proquest_miscellaneous_902087554 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Acetylglucosaminidase - urine Acute-Phase Proteins - urine Aged Albuminuria Biological and medical sciences Cardio-Renal Syndrome - physiopathology Cardio-Renal Syndrome - urine Cardiology. Vascular system Chronic Disease Female Glomerular Filtration Rate - physiology Heart Heart failure, cardiogenic pulmonary edema, cardiac enlargement Hepatitis A Virus Cellular Receptor 1 Humans Kidney Tubules - physiopathology Lipocalin-2 Lipocalins - urine Male Medical sciences Membrane Glycoproteins - urine Middle Aged Multicenter Studies as Topic Proto-Oncogene Proteins - urine Randomized Controlled Trials as Topic Receptors, Virus |
title | Clinical outcome of renal tubular damage in chronic heart failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A53%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20outcome%20of%20renal%20tubular%20damage%20in%20chronic%20heart%20failure&rft.jtitle=European%20heart%20journal&rft.au=Damman,%20Kevin&rft.date=2011-11-01&rft.volume=32&rft.issue=21&rft.spage=2705&rft.epage=2712&rft.pages=2705-2712&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehr190&rft_dat=%3Cproquest_cross%3E902087554%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=902087554&rft_id=info:pmid/21666249&rft_oup_id=10.1093/eurheartj/ehr190&rfr_iscdi=true |